Wave Life Sciences Ltd (WVE) — Cash Flow Reinvestment Rate
Latest as of March 2023:
0.01x
Wave Life Sciences Ltd (WVE) has a Cash Flow Reinvestment Rate of 0.01x as of March 2023, reinvesting $978.00K (capex $489.00K plus investments $-489.00K) from operating cash flow of $85.52 Million. Check WVE cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.01x
(Capex + Investments) / Operating CF
Total Reinvested
$978.00K
Capex + Investments
Operating Cash Flow
$85.52 Million
USD
Capital Expenditures
$489.00K
USD
Annual Cash Flow Reinvestment Rate for Wave Life Sciences Ltd (None–None)
Year-by-year capital reinvestment analysis for Wave Life Sciences Ltd. For live market cap and broader valuation context, see market value of Wave Life Sciences Ltd.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow